Washington – Moderna said its clinical trial data showed its updated Covid-19 vaccine can effective against the highly-mutated BA.2.86 subvariant that has raised fears of a resurgence of infections. Moderna head of infectious diseases Jacqueline Miller said in an interview: “We think this is news people will want to hear as they prepare to go out and get their fall …